Crossmark

The effect of rivaroxaban on biomarkers in blood and plasma: a review of preclinical and clinical evidence

Published Online: 2023-02-06

Authors

Schiffer, Sonja https://orcid.org/0000-0001-9708-691X
Schwers, Stephan

Heitmeier, Stefan
License Information

Text and Data Mining valid from 2023-02-06

Version of Record valid from 2023-02-06
More Information

Article History

Accepted: 15 January 2023

First Online: 6 February 2023

Declarations

:

: All authors are employees of Bayer AG.

: Not applicable.

: Not applicable.

Document is current